Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation — Stella

Recruiting

Back to Liver Metastasis Colon Cancer trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Denmark

Aarhus University Hospital, Department of Surgery, Aarhus

Key details

Sponsor

University of Aarhus

Collaborators

Aarhus University Hospital, Rigshospitalet, Denmark

Enrollment target

~200 participants

Started

November 2022

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 99 Years

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov